DNA strand breaks and mutations caused by penbutolol, a beta blocker

This publication has 9 references indexed in Scilit:

• Mutagenic evaluation of propranolol in somatic and germ cells of mice
  Mutation Research Letters, 1986
• Determination of propranolol in plasma by radial compression liquid chromatography with fluorometric detection.
  Clinical Chemistry, 1985
• Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver
  Cancer Letters, 1984
• Thyroid modifications in male and female rats treated with the hepatocarcinogen beta-blocker ZAMI 1305
  Cancer Letters, 1983
• Studies on the possible mutagenicity of β-adrenergic blocker drugs
  Toxicology Letters, 1983
• Revised methods for the Salmonella mutagenicity test
  Mutation Research/Environmental Mutagenesis and Related Subjects, 1983
• Penbutolol
  Drugs, 1981
• A carcinogenicity study in mice of a ß-adrenergic antagonist, primidolol; Increased total tumour incidence without tissue specificity
  Toxicology, 1981
• Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking Agent
  Nature, 1967